Related Experiment Video
Updated: Dec 15, 2025

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
PDGFA gene rs9690350 polymorphism increases biliary atresia risk in Chinese children
Fei Liu1, Jixiao Zeng1, Deli Zhu1
1Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
Insights
Genetic variants in Platelet-Derived Growth Factor Subunit A (PDGFA) are linked to biliary atresia (BA) risk in infants. The rs9690350 G allele in PDGFA increases susceptibility to BA and non-cystic BA.
Area of Science:
- Genetics
- Pediatric Gastroenterology
- Molecular Biology
Background:
- Biliary atresia (BA) is a severe neonatal cholestatic liver disease with unclear pathogenesis.
- Platelet-derived growth factor subunit A (PDGFA) is implicated in liver fibrosis, and its overexpression may contribute to BA development.
- Genetic factors are suspected to play a role in BA etiology.
Purpose of the Study:
- To investigate the association between genetic variants in PDGFA and the susceptibility to biliary atresia (BA).
- To explore the potential of PDGFA polymorphisms as biomarkers for BA risk and disease severity.
Main Methods:
- A large case-control cohort study was conducted.
- The study included 506 BA cases and 1473 controls from the Southern Chinese population.
- Genetic variants in PDGFA, specifically the rs9690350 (G>C) polymorphism, were analyzed.
Main Results:
- The G allele of rs9690350 in PDGFA was significantly associated with an increased risk of BA (OR = 1.24, P=0.02).
- This G allele also increased the risk of non-cystic biliary atresia (OR = 1.26, P=0.02).
- The rs9690350 G allele was identified as a genetic biomarker for severe post-operative manifestations in BA patients.
Conclusions:
- The rs9690350 G allele in PDGFA is a genetic polymorphism associated with increased susceptibility to biliary atresia.
- This finding suggests a potential role for PDGFA in BA pathogenesis.
- PDGFA genetic variants may serve as biomarkers for BA risk and disease severity.
Abstract:
Biliary atresia (BA) is a genetic and severe fibro-inflammatory obliterative cholangiopathy of neonates. Platelet-derived growth factor subunit A (PDGFA), as one of participants in liver fibrosis, the overexpression of PDGFA through DNA hypomethylation may lead to the development of BA, but the pathogenesis is still unclear. We conducted a large case-control cohort to investigate the association of genetic variants in PDGFA with BA susceptibility in the Southern Chinese population (506 cases and 1473 controls). We observed that the G allele of rs9690350(G>C) in PDGFA was significantly associated with an increased risk of BA (OR = 1.24, 95% CI = 1.04-1.49, P=0.02). Additionally, the rs9690350 G allele increased the risk of non-cystic biliary atresia (OR = 1.26, 95% CI = 1.04-1.52, P=0.02) and was a genetic biomarker of severe manifestations after surgery. These findings indicate that the rs9690350 G allele is a PDGFA polymorphism associated with the risk of BA that may confer increased disease susceptibility.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

